7月30日，科伦博泰生物盘中下跌3.01%，报482.6港元/股，成交额5705.1万港元。
科伦博泰生物所在的生物科技行业中，板块整体走弱，个股中，信达生物跌1.9%，康方生物跌2.25%，百济神州跌1.71%，三生制药跌2.06%，荣昌生物跌3.2%。
科伦博泰生物是一家主要从事肿瘤学、免疫学及其他治疗领域创新药物研发、制造及商业化的公司，核心产品包括抗体药物偶联物（ADC）SKB264等，主要用于乳腺癌、非小细胞肺癌、胃肠道癌等疾病的治疗。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.